Epidermolysis bullosa is a pathology caused by mutations in the COL7A1 gene, responsible for the production of collagen seven. The specialist mentioned in the article explained this genetic condition.
As a result of these mutations, patients develop blisters, deep wounds and face a high risk of infectious complications. The disease affects the skin and mucous membranes of patients.
The article highlights that there is no cure for epidermolysis bullosa. Furthermore, available treatments have very high costs, representing a significant challenge for patients and their families.




